How does Imatinib 400mg Tablet work?

This is an anti-cancer medication. This medication belongs to a class of medicines known as tyrosine kinase inhibitors. This medicine stops the growth of cancer cells and also prevents the multiplication of cancer cells.

What are the side effects of Imatinib 400mg Tablet?

Some common side effects of the Imatinib tablet are abdominal pain, fatigue, anxiety, vomiting, muscle pain, nausea, rash, joint pain, difficulty in breathing, etc.

Can I consume alcohol while taking this medicine?

It is not known whether it is safe or not. Please consult your doctor before consuming alcohol while taking this medicine.

Can I take this medicine during breastfeeding?

This medicine is not recommended for breastfeeding unless it is necessary.

Deal of the Day — limited-time pharmacy picks!Deal of the Day — today's spotlight pharmacy prices, refreshed daily.

Imatinib mesylate 400mg Tablet

Rx Required

Salt Composition: Imatinib mesylate

Expiry Date: 01/2028

Buy at $30.59

$30.59

Inclusive of all taxes

▼

3x10 tablet

About The Product

Blood Cancer

Imatinib mesylate 400mg Tablet belongs to a class of medication known as tyrosine kinase inhibitors. It is an anticancer medicine that is commonly prescribed to treat certain blood cancers like chronic myeloid leukemia & acute lymphocytic leukemia, and gastrointestinal stromal tumors. It works as a specific inhibitor of several tyrosine kinase enzymes. After the oral administration, the effect of this medicine can be observed in 2-4 hours.

Side Effects

Like any other medicine, Imatinib mesylate 400mg Tablet also has some adverse effects on the body, and most of them are manageable without special medical attention.

Some common side effects include:

Difficulty in breathing
Indigestion
Constipation
Weight loss
Acidic stomach
Change in taste
Dry mouth
Joint pain
Irregular heartbeat
Unusual bleeding
Presence of blood in coughing
Abdominal pain.
Swelling around the eyes

Do not forget to discuss the risks and benefits of this medication with your doctor. Seek medical attention immediately in case of any severe issues.

Safety Advice

Alcohol

The interaction of alcohol with this drug is still unknown. It is advisable not to consume alcohol while taking Imatinib 400mg Tablet.

Pregnancy

Do not take Imatinib 400mg Tablet without consulting the doctor in case of pregnancy.

Breast Feeding

Imatinib 400mg Tablet is unsafe to use during breastfeeding as it may cause toxicity to the baby. It is safe if prescribed.

Driving

Imatinib 400mg Tablet may cause side effects such as dizziness or lack of concentration, which could affect your ability to drive. So it's better to avoid driving or operating heavy machinery.

Kidney

Consumption of Imatinib 400mg Tablet should be avoided without informing the doctor if you have any kidney-related issues.

Liver

Consumption of Imatinib 400mg Tablet should be avoided without informing the doctor if you have any liver-related issues.

FAQs

Imatinib tablet is used to treat certain types of cancer, such as chronic myeloid leukemia, acute lymphocytic leukemia, and gastrointestinal stromal tumors.

Reference

https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021588s047lbl.pdf
Cohen, M. H., Johnson, J. R., & Pazdur, R. (2005). US Food and Drug Administration Drug Approval Summary: conversion of imatinib mesylate (STI571; Gleevec) tablets from accelerated approval to full approval. Clinical cancer research, 11(1), 12-19 - https://www.semanticscholar.org/paper/U.S.-Food-and-Drug-Administration-Drug-Approval-of-Cohen-Johnson/dd03728666a054549c5c1d9b7fecd81afee95fda
Nikolova, Z., Peng, B., Hubert, M., Seiberling, M., Keller, U., Ho, Y. Y., ... & Capdeville, R. (2004). Bioequivalence, safety, and tolerability of imatinib tablets compared with capsules. Cancer chemotherapy and pharmacology, 53(5), 433-438.
Devi, N. A., Hadi, M. A., Rajitha, P., Sharma, J. V. C., & Rao, A. S. (2013). Formulation and evaluation of floating controlled release tablets of imatinib mesylate using hydrophilic matrix system. Int J Pharm Pharm Sci, 5(1), 271-277.

Last updated: 5 Aug 2026 | 04:32 PM (IST)

Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only

Not a substitute for professional medical advice

Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.

Read full medical disclaimer in Terms & Conditions